81 related articles for article (PubMed ID: 2823686)
1. The role of vitamin D3 in the proliferation of a human colon cancer cell line in vitro.
Lointier P; Wargovich MJ; Saez S; Levin B; Wildrick DM; Boman BM
Anticancer Res; 1987; 7(4B):817-21. PubMed ID: 2823686
[TBL] [Abstract][Full Text] [Related]
2. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
Dokoh S; Donaldson CA; Haussler MR
Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995
[TBL] [Abstract][Full Text] [Related]
3. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells.
Koga M; Eisman JA; Sutherland RL
Cancer Res; 1988 May; 48(10):2734-9. PubMed ID: 2834048
[TBL] [Abstract][Full Text] [Related]
4. The effects of steroid hormones on a human colon cancer cell line in vitro.
Lointier P; Wildrick DM; Boman BM
Anticancer Res; 1992; 12(4):1327-30. PubMed ID: 1503430
[TBL] [Abstract][Full Text] [Related]
5. The involvement of calcium ions in the effect of 1,25-dihydroxyvitamin D3 on HL-60 cells.
Levy R; Nathan I; Barnea E; Chaimovitz C; Shany S
Exp Hematol; 1988 May; 16(4):290-4. PubMed ID: 3129299
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of antimitogenic action of vitamin D in human colon carcinoma cells: relevance for suppression of epidermal growth factor-stimulated cell growth.
Tong WM; Hofer H; Ellinger A; Peterlik M; Cross HS
Oncol Res; 1999; 11(2):77-84. PubMed ID: 10489163
[TBL] [Abstract][Full Text] [Related]
7. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
8. Induction of anchorage-independent growth of JB6 mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3.
Hosoi J; Abe E; Suda T; Colburn NH; Kuroki T
Cancer Res; 1986 Nov; 46(11):5582-6. PubMed ID: 3019530
[TBL] [Abstract][Full Text] [Related]
9. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3.
Eisman JA; Barkla DH; Tutton PJ
Cancer Res; 1987 Jan; 47(1):21-5. PubMed ID: 3024816
[TBL] [Abstract][Full Text] [Related]
10. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
11. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
12. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
Levy Y; Knutson JC; Bishop C; Shany S
Anticancer Res; 1998; 18(3A):1769-75. PubMed ID: 9673403
[TBL] [Abstract][Full Text] [Related]
13. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.
Barreto AM; Schwartz GG; Woodruff R; Cramer SD
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):265-70. PubMed ID: 10750664
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites.
Frampton RJ; Omond SA; Eisman JA
Cancer Res; 1983 Sep; 43(9):4443-7. PubMed ID: 6307514
[TBL] [Abstract][Full Text] [Related]
16. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
17. Biological activities of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 on human promyelocytic leukemic HL-60 cells: effects of fetal bovine serum and of incubation time.
Okuno S; Inaba M; Nishizawa Y; Morii H
Miner Electrolyte Metab; 1995; 21(1-3):211-6. PubMed ID: 7565452
[TBL] [Abstract][Full Text] [Related]
18. Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid.
Hosoi J; Abe E; Suda T; Kuroki T
Cancer Res; 1985 Apr; 45(4):1474-8. PubMed ID: 2983883
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3.
Shabahang M; Buras RR; Davoodi F; Schumaker LM; Nauta RJ; Uskokovic MR; Brenner RV; Evans SR
Cancer Res; 1994 Aug; 54(15):4057-64. PubMed ID: 8033137
[TBL] [Abstract][Full Text] [Related]
20. Biochemical significance of enhanced activity of fluorinated 1,25-dihydroxyvitamin D3 in human cultured cell lines.
Eisman JA; Frampton RJ; McLean FJ
Cell Biochem Funct; 1986 Apr; 4(2):115-22. PubMed ID: 3011306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]